Natera Inc (NTRA)
146.06
-5.05
(-3.34%)
USD |
NASDAQ |
Nov 15, 16:00
146.24
+0.18
(+0.12%)
After-Hours: 20:00
Natera Revenue (Annual): 1.083B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.083B |
| December 31, 2022 | 820.22M |
| December 31, 2021 | 625.49M |
| December 31, 2020 | 391.00M |
| December 31, 2019 | 302.33M |
| December 31, 2018 | 257.65M |
| Date | Value |
|---|---|
| December 31, 2017 | 209.62M |
| December 31, 2016 | 212.51M |
| December 31, 2015 | 190.36M |
| December 31, 2014 | 159.29M |
| December 31, 2013 | 55.17M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
302.33M
Minimum
2019
1.083B
Maximum
2023
644.32M
Average
625.49M
Median
2021
Revenue (Annual) Benchmarks
| Progyny Inc | 1.089B |
| Delcath Systems Inc | 2.065M |
| Star Equity Holdings Inc | 45.78M |
| Exact Sciences Corp | 2.500B |
| CytoSorbents Corp | 31.08M |